The full-year revenue was a 2 percent increase from $421 million in 2019, the release said. Total revenue includes net product sales of Exparel and Iovera.
Highlights from Pacira’s fourth quarter include $125.3 million in net sales for Exparel and $22.4 million for Iovera, the release said. The company also saw $1.2 million in royalty revenue in 2020.
Read more details and figures from the fourth quarter here.
More articles on devices:
HOPCo, Ascension joint venture spine hospital opens in Florida; Georgia expansion planned
Stryker makes 1st acquisition of 2021: 4 details
As bundle participation declines, orthopedics looks to increased risk sharing and population health
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
